Gene | Score gda | Association Type | Type | Original DB | Sentence supporting the association | PMID | PMID Year | ||||
---|---|---|---|---|---|---|---|---|---|---|---|
|
0.090 | Biomarker | disease | BEFREE | A simple immunohistochemical bio-profile incorporating Bcl2 curbs those cases of invasive breast carcinoma for which an Oncotype Dx characterization is needed. | 31158261 | 2019 | ||||
|
0.090 | Biomarker | disease | BEFREE | The aim of this study was to assess the prognostic significance of Bcl-2 according to the molecular tumor subtype in primary invasive breast cancer patients. | 25682076 | 2015 | ||||
|
0.090 | Biomarker | disease | BEFREE | The function role of miR-181a in chemosensitivity to adriamycin by targeting Bcl-2 in low-invasive breast cancer cells. | 24335172 | 2013 | ||||
|
0.090 | AlteredExpression | disease | BEFREE | Tissue microarrays were used to assess the expression of Ki67 and BCL2 in 2749 cases of invasive breast cancer. | 21953021 | 2012 | ||||
|
0.090 | AlteredExpression | disease | BEFREE | Since BAG-1 interacts with Bcl-2 and is upregulated by mutant p53 in vitro, it would be interesting to determine if their expressions are correlated with each other and with other clinical prognostic factors in invasive breast cancer. | 15026618 | 2004 | ||||
|
0.090 | Biomarker | disease | BEFREE | Thymidine phosphorylase expression correlates with tumor differentiation and Bcl-2 in invasive breast cancer. | 11029800 | 2000 | ||||
|
0.090 | AlteredExpression | disease | BEFREE | Expression of Bcl-2, but not Bax, correlates with estrogen receptor status and tumor proliferation in invasive breast carcinoma. | 10504548 | 1999 | ||||
|
0.090 | Biomarker | disease | BEFREE | Loss of Bcl-2 in invasive breast cancer is associated with high rates of cell death, but also with increased proliferative activity. | 9514059 | 1998 | ||||
|
0.090 | AlteredExpression | disease | BEFREE | Prognostic value of bcl-2 expression in invasive breast cancer. | 7640218 | 1995 |